Supreme Court Ruling Bolsters Licensee Rights
In an 8-1 decision that may lead more licensees to challenge patents, the Supreme Court on Tuesday sided with biotech company MedImmune Inc. in a royalty dispute with Genentech Inc. over...To view the full article, register now.
Already a subscriber? Click here to view full article